THE NEWS

The surge in tech hiring in the U.S. in 2021 and 2022 represented one of the most aggressive talent grabs in industry history, only to be followed by widespread layoffs and hiring freezes as economic headwinds and post-pandemic corrections hit the sector.

This dramatic swing has reshaped the software development job market, leaving both companies and developers to navigate a new landscape of cautious growth and strategic hiring.

This graphic, via Visual Capitalist’s Kayla Zhu, shows the percent change in software development job postings on Indeed U.S. since Feb. 1, 2020 to Feb. 28, 2025.

The data comes from Indeed via the Federal Reserve and is updated as of March 2025. Figures are seasonally-adjusted.

The U.S. Software Developer Hiring Boom Is Over

Below, we show the percent change in software development job postings on Indeed U.S. since Feb. 1, 2020 to Feb. 28, 2025.

Breaking into tech as a software developer in 2025 won’t be as easy as it was before—job listings are at their lowest in five years, down more than 33% from 2020 levels.

Software development job postings soared in 2021 and 2022 as tech companies expanded rapidly, fueled by economic recovery and a surge in startup funding.

However, hiring slowed dramatically in 2023 as economic uncertainty, widespread layoffs, and reduced venture capital investment hit the industry.

Some other factors behind the decline in software developer jobs include the widespread adoption of AI-powered software development tools that enhance productivity and a shift in focus by tech companies toward efficiency rather than expansion.

Despite the overall decline in software development job postings, major tech hubs like the San Francisco Bay Area and New York have continued to see net job growth in the tech sector, including developer roles, over the past few years.

To learn more trends in the programming world, check out this graphic that ranks the most popular programming languages on GitHub from 2014 to 2024.

Authored by Jeremy Portnoy via RealClearInvestigations,

Topline: A Chinese lab is continuing to receive funds from the U.S. to conduct cruel studies on beagles, according to contracts obtained by the nonprofit White Coat Waste Project and shared with the New York Post.

Key facts: The $124,200 contract was awarded by the National Institutes of Health’s National Center for Advancing Translational Sciences using money from the Pentagon, for the experiments on beagle puppies — as well as mice and rats — at the Beijing-based company’s lab from September 2023 until May 2025.

The Chinese company Pharmaron uses the funds to test pharmaceuticals for neurological disorders on 300 beagles per week, as well as mice and rats, White Coat Waste found. Some of the dogs are as young as eight months. Those that suffer organ dysfunction are euthanized, the contract states.

Pharmaron’s proposal to the NIH promises to comply with the Animal Welfare Act and notes that “Beagle dog is docile, cute and easy to domesticate.”

It describes how the hundreds of dogs, some as young as eight months, “will be reused” throughout the study “to save animals and decrease cost,” while saying those suffering organ dysfunction will be “euthanized.”

The DOD’s Office of Inspector General conducted an audit in June, citing Pharmaron, as well as the Chinese biotech firms WuXi AppTec and Genscript Inc., as so-called “companies of concern” and blacklisted from doing business with U.S. firms. A bill to this effect passed the U.S. House of Representatives but was not voted on in the Senate.

Background: The research contract is just one example of how the U.S. and China fund each other’s medical research, often resulting in payouts for government scientists and potential national security concerns at taxpayers’ expense.

In 2023, 139 foreign companies licensed medical technology invented by NIH scientists, compared to only 102 domestic companies. The businesses included Pokrov Biologics Plant, which researched the weaponization of smallpox for the Soviet Union during the Cold War, and WuXi AppTec, a Chinese firm with alleged military ties and alleged access to American genetic information.

Search all federal, state and local government salaries and vendor spending with the AI search bot, Benjamin, at OpenTheBooks.com. 

Critical quote: Rep. Nicole Malliotakis (R-NY) claims the federal government spends $20 billion each year on animal testing.

“Donald Trump’s Department of Government Efficiency has elevated the problem of wasteful spending from think-tank white papers to a national cover story,” Malliotakis wrote in an op-ed in the Post. “With $36 trillion in national debt — more than $300,000 per taxpayer — there’s a lot of spending to slash. What better way to start than by cutting the $20 billion the government wastes every year on dead-end experiments that torture dogs, cats and other animals?”

Summary: Contract oversight is difficult enough when funds stay within America. Foreign contracts open up even more issues and should only be awarded after strict scrutiny.